| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy’s risk assessments do not address all the key risks with the pharmacy’s services. This includes its use of unlicenced preparations and potential side effects of topical formulations. And the risk assessments don’t refer to established practice or evidence-based use for these unlicenced preparations. So some key risks affecting patient safety may be missed. |
To address this, a detailed risk assessment will be added to the existing one to specifically identify clinical, operational, and patient safety risks associated with unlicensed medicines, along with appropriate control measures. In addition, our SOPs for unlicensed medicines will be reviewed and updated to incorporate specific processes including prescriber verification, patient counselling, and incident reporting. A literature review and summary of clinical evidence supporting the use of unlicensed preparations will also be completed and appended to the SOPs to ensure an evidence-based approach is maintained |
18/11/2025 | 15/11/2025 |
| 3.1 | The pharmacy has updated parts of its website following the previous inspection. But the homepage promotes prescription only medicines with associated prices, and there is wording that makes unsubstantiated medicinal claims about unlicensed medicines. This is not in line with requirements for promoting medicines to the public, and can be misleading for people using the website. |
We are already working closely with our team to review and update the website to address these issues and ensure full compliance with GPhC guidance on online pharmacy practice. |
18/11/2025 | 15/11/2025 |
Pharmacy inspections
Inspection reports and learning from inspections